PharmaEssentia (TPE:6446) Common Stock: NT$3,796 Mil (As of Dec. 2025)


TPE:6446 PharmaEssentia Corp TPE:6446
82 GF Score
Price NT$1,285.00
GF Value NT$1,214.13
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is PharmaEssentia Common Stock?

PharmaEssentia TPE:6446 82 Common Stock is NT$3,796 Mil as of Dec. 2025. GuruFocus rates TPE:6446 with a GF Score™ of 82/100 and a GF Value™ of NT$1,214.13 (Fairly Valued). The stock has 5 warning signs investors should review.

PharmaEssentia's quarterly common stock increased from Jun. 2025 (NT$3,788 Mil) to Sep. 2025 (NT$3,788 Mil) and increased from Sep. 2025 (NT$3,788 Mil) to Dec. 2025 (NT$3,796 Mil).

PharmaEssentia's annual common stock increased from Dec. 2023 (NT$3,403 Mil) to Dec. 2024 (NT$3,418 Mil) and increased from Dec. 2024 (NT$3,418 Mil) to Dec. 2025 (NT$3,796 Mil).

PharmaEssentia Common Stock Historical Data

* Premium members only.

The historical data trend for PharmaEssentia's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PharmaEssentia Common Stock Chart

PharmaEssentia Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,769.04 3,024.56 3,402.64 3,417.91 3,796.29

PharmaEssentia Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,417.91 3,419.47 3,787.87 3,787.99 3,796.29
TPE:6446
82GF Score
PharmaEssentia Corp TPE:6446
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PharmaEssentia Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of NT$3,796 Mil mean?
PharmaEssentia (TPE:6446) has a Common Stock of NT$3,796 Mil as of Dec. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on PharmaEssentia and its competitors.
Is PharmaEssentia's Common Stock too high?
PharmaEssentia's current Common Stock is NT$3,796 Mil. Overall, PharmaEssentia has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does PharmaEssentia's Common Stock compare to ZTS and UTHR?
PharmaEssentia's Common Stock of NT$3,796 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Drug Manufacturers company?
A good Common Stock depends on the Drug Manufacturers industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on PharmaEssentia and its competitors. PharmaEssentia's current Common Stock is NT$3,796 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PharmaEssentia stock overvalued right now?
Based on GuruFocus' analysis, PharmaEssentia (TPE:6446) is currently considered Fairly Valued. The stock's GF Value™ is NT$1,214.13, compared to a current price of NT$1,285.00 — trading 5.8% above its estimated fair value. The current Common Stock is NT$3,796 Mil. PharmaEssentia's overall GF Score™ is 82/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For PharmaEssentia (TPE:6446), the current Common Stock is NT$3,796 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PharmaEssentia (TPE:6446) Overvalued in 2026?

Based on GuruFocus' analysis, PharmaEssentia stock appears to be overvalued. The current stock price of NT$1,285.00 is trading 5.8% above its estimated GF Value™ of NT$1,214.13. GuruFocus considers PharmaEssentia to be Fairly Valued.

Key valuation signals for TPE:6446:

  • Common Stock: NT$3,796 Mil
  • GF Value™: NT$1,214.13 vs. price of NT$1,285.00 (5.8% above fair value)
  • GF Score™: 82/100 with 5 warning signs

No single metric tells the full story. See the TPE:6446 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PharmaEssentia Business Description

Address 13th Floor, No.3, Park Street, Nangang District, Taipei, TWN, 115
PharmaEssentia Corp engages in medicine discovery, supplements in developing specialty pharmaceutical reagents, API and new drug patterns developments. Its products include BESREMi, Ropeginterferon alfa-2b, Ropeg + anti PD-1, PEG-IL-2, PEG-Cytokines, PD-1-IL-2v, NY-ESO-1 TCR-T, among others. It derives revenue from medicine products sales from contracts with customers.
82GF Score

Get the complete analysis for TPE:6446

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$1,285.00
Price
NT$1,214.13
GF Value